Why Amazon stock stumbled today

Investors sell out of the company, albeit modestly, after a rival's bid is selected for a choice asset.

| More on:
A businessman slips and spills his coffee.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

What happened

Monster retailer Amazon (NASDAQ: AMZN) doesn't often lose, so shareholders get discouraged when the company doesn't come in first in a contest. That was the situation on Tuesday, when a rival's bid was selected for a big healthcare asset that was in play. As a result, Amazon's share price closed the day over 1% lower, a steeper fall than that of the S&P 500 index.

So what

Amazon was vying for healthcare services company Signify Health, but the nod ended up going to CVS Health, whose bid was worth roughly $8 billion. Other companies participating in the effort to acquire Signify were UnitedHealth Group and Option Care Health.

Among that crowd, Amazon was a bit of an outlier. UnitedHealth and Option Care are pure-play healthcare companies. Amazon, which has always aimed to be a retailer of any product or service imaginable, is still considered by many to be more of a giant online shopping outlet than a provider of healthcare services.

In Signify's press release announcing its selection of CVS, CEO Kyle Armbrester said that "we determined that CVS Health is the ideal partner, given its focus on expanding access to health services and helping consumers navigate to the best sites of care."

While Amazon has indisputably made strides in its medical business efforts -- witness its $3.9 billion deal for primary care provider 1Life Healthcare earlier this year -- it still isn't readily identified with that sector. It wouldn't be surprising if this made the company a dark horse candidate, at best, in the Signify bidding.

Now what

Amazon isn't known for setbacks and management probably isn't too fond of them, so we can expect the company to make fresh bids for other healthcare businesses that come into play. But other entities with deep pockets will also be looking to buy, so Signify might not be the last of its defeats in the sector.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Eric Volkman has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Amazon. The Motley Fool Australia has recommended Amazon. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on International Stock News

A man looking at his laptop and thinking.
International Stock News

Why Alphabet stock was sliding today

Let's take a look.

Read more »

A man looking at his laptop and thinking.
International Stock News

Nvidia's stock was down despite its amazing earnings. Here's what history says is coming next

Although it might seem to defy logic, it's not an uncommon phenomenon.

Read more »

A woman holds a soldering tool as she sits in front of a computer screen while working on the manufacturing of technology equipment in a laboratory environment.
International Stock News

Nvidia share price slips despite 94% revenue growth

Q3 earnings beat expectations, but what about guidance?

Read more »

high, climbing, record high
International Stock News

Could the S&P 500 Index hit 6,500 by the end of 2025?

Could the index climb higher?

Read more »

a small child holds his chin with his head on the side in a serious thinking pose against a background of graphic question marks and a yellow lightbulb.
International Stock News

Is it too late to buy Nvidia shares?

Is Nvidia stock a buy ahead of its third-quarter earnings report tomorrow?

Read more »

a group of people stand examining a large glowing cystral ball held in the hands of one of the group members while the others regard it with various expressions of wonder, curiousity and scepticism.
International Stock News

Here's what to expect from Nvidia on November 20

Can Nvidia score another win?

Read more »

Two people lazing in deck chairs on a beautiful sandy beach through their hands up in the air.
International Stock News

2 no-brainer Warren Buffett stocks to buy right now

While replicating Buffett's success isn't possible, there are a handful of his investments that are no-brainer buys.

Read more »

A man with a beard and wearing dark sunglasses and a beanie head covering raises a fist in happy celebration as he sits at is computer in a home environment.
International Stock News

3 reasons to buy Nvidia stock before November 20

This week marks a big moment for tech investors as perhaps the most anticipated earnings of the year will be…

Read more »